Selank

Selank

Selank is a synthetic heptapeptide tuftsin analogue developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, approved in Russia for anxiety treatment and nootropic use, and studied internationally for anxiety modulation, cognitive enhancement, and brain function support. Licensed practitioners interested in buying Selank can contact Medical Spa Rx’s professional support team for guidance on sourcing from qualified suppliers and for access to supporting documentation, including purity information. This page provides an overview of Selank and its research applications through the sections and FAQ below.

Selank Nasal Spray, Dosage & Administration

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TP-7), derived from tuftsin — an endogenous immunomodulatory tetrapeptide fragment of IgG — and modified with a C-terminal Pro-Gly-Pro tripeptide to improve metabolic stability. It was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and is reported in Russian sources as registered for generalized anxiety disorder and nootropic use.

Selank Nasal Spray: Primary Administration Route

Nasal spray is the most commonly referenced route in Russian clinical practice and practitioner-reported protocols, aligning with the formulation available in the Russian market. Practitioner-reported dosing via nasal spray (non-FDA-validated):

• Dose: 250–750 mcg per nostril, 2–3 times daily, based on Russian clinical parameters and practitioner experience. No FDA-validated intranasal protocol exists for Selank outside authorized Russian clinical settings.

Selank Injectable Route

Subcutaneous administration is less common than nasal spray but appears in practitioner-reported protocols outside Russian clinical settings (non-FDA-validated):

• Dose: 250–500 mcg once or twice daily, based on practitioner experience outside Russian clinical settings.
• Storage: Refrigerate at 2–8°C; protect from light. Nasal spray formulations may have a limited post-opening shelf life — confirm usage windows and handling in accordance with the documentation for the sourced formulation.

What Does Selank Do? Mechanism of Action

Selank is an anxiolytic and nootropic peptide with several proposed mechanisms linked to anxiety modulation, cognitive support, and brain function:

• Enkephalinase inhibition (the primary and most clinically distinctive mechanism): Selank inhibits enkephalinase, the enzyme that degrades endogenous enkephalins [2]. By slowing that breakdown, it extends the activity of peptides involved in mood regulation, stress response, and anxiolytic signaling — a mechanism distinct from direct benzodiazepine receptor binding. In vitro data show an IC₅₀ of approximately 15 μM, with potency exceeding that of bacitracin and puromycin [2].
• GABAergic modulation: Selank appears to indirectly modulate GABA-A receptor expression, producing benzodiazepine-like anxiolytic effects without the receptor-level mechanisms associated with sedation, tolerance, and dependence. A 2020 human neuroimaging study using fMRI in 52 healthy participants found that Selank altered amygdala connectivity — a key anxiety-regulating region — providing objective human evidence consistent with central nervous system effects relevant to anxiolytic action [4].
• Serotonergic and dopaminergic modulation: In preclinical animal models, Selank has been shown to alter monoamine turnover in limbic regions involved in mood and motivation. Human data mapping these exact neurotransmitter shifts is limited; this rodent data is most often cited to support Selank’s secondary relevance as a nootropic agent rather than as a primary clinical mechanism.
• BDNF upregulation: Intranasal Selank administration in rats produced a 1.5–2-fold increase in hippocampal BDNF mRNA at 3 hours post-administration, with a sustained 30% increase at 24 hours [3]. Because BDNF is involved in neuroplasticity, memory consolidation, and learning pathways, this mechanism is cited in discussions of cognitive enhancement and brain function.
• Immune modulation: As a tuftsin analogue, Selank has been studied for potential immunomodulatory effects. Isolated in vitro and animal literature suggests it may influence inflammatory cytokines, including IL-6 and IL-1β. These findings are strictly secondary and lack validation in human clinical trials.

Note on copper peptide terminology: Selank occasionally appears alongside search terms such as “copper peptide” or “purity of copper.” It is not a copper peptide and contains no copper. Selank belongs to the anxiolytic and nootropic peptide category, not the GHK-Cu or cosmetic anti-aging class.

Selank Peptide Benefits, Side Effects & Safety

Selank peptide benefits are most commonly discussed in relation to anxiety reduction, cognitive clarity, stress modulation, and support for brain function. A 2008 Russian clinical trial by Zozulya and colleagues evaluated Selank against the benzodiazepine medazepam in 62 patients and reported equivalent anxiolytic efficacy, along with antiasthenic and mild psychostimulant effects—benefits not observed with the benzodiazepine comparator [1]. All benefit claims should be framed as Russian clinical, preclinical, or practitioner-reported rather than broadly established in Western RCTs.

Selank is generally well tolerated in Russian clinical trials, with no serious adverse events documented at studied doses [1]. Its safety profile compares favorably to benzodiazepines for the anxiety indication, primarily because it does not carry the same sedation, tolerance, or physical dependence risk.

Side Effects

• Nasal irritation or local discomfort: most common concern with intranasal use; typically mild
• Transient headache: reported at low frequency
• No sedation, tolerance development, or physical dependence reported at research doses [1] — clinically as important as the side effect list itself

Selank Withdrawal

No physical dependence or withdrawal syndrome has been reported in either Russian clinical literature or practitioner-reported experience [1]. This is a key differentiator from the benzodiazepine class. Long-term safety data outside Russian clinical settings remain limited, and this gap should be communicated clearly in any protocol discussion.

Current Legal Status of Selank

• Russia and Belarus: Reported in Russian regulatory sources as registered as a prescription medication for generalized anxiety disorder and as a nootropic agent. Formal regulatory status exists in these markets, though trial standards and regulatory processes differ from those of the FDA, EMA, and TGA
• United States (current as of mid 2026): Not FDA-approved for any indication. Selank is not listed on the FDA 503A compounding list for office-based use. It is classified as a research compound only and has no approved clinical use outside authorized Russian regulatory settings.
• Australia (current as of mid 2026): Not approved by the Australian Therapeutic Goods Administration (TGA) for any therapeutic indication. Compounding or sourcing should be verified against jurisdiction-specific pharmaceutical regulations under the Therapeutic Goods Act 1989.
• WADA (current as of mid 2026): Selank is not expressly named on the official 2026 WADA Prohibited List. However, athletes in regulated competition should verify the latest status before use, as the Prohibited List is updated annually and peptide classifications can change. The List includes a catch-all category for substances without current government therapeutic approval, which could apply to research compounds such as Selank.

All regulatory details are subject to change. Practitioners should confirm current requirements in their jurisdiction before procurement or protocol consideration.

Selank vs DSIP & Selank vs Oxytocin

Both Selank and Semax are Russian-developed nootropic peptides with domestic regulatory approval, but they serve different primary purposes. Selank is an anxiolytic and calming nootropic — relevant to generalized anxiety, stress-related cognitive symptoms, and brain function support via enkephalinase inhibition and GABAergic action confirmed in human neuroimaging data [4]. Semax is more cognitively activating and is discussed primarily in relation to attention, processing speed, and neuroprotection via BDNF upregulation and ACTH-like mechanisms. The choice between them depends on whether the protocol calls for anxiolytic and calming nootropic support or stimulating cognitive enhancement.

versus DSIP

Selank and DSIP both relate to stress regulation, but they target different phases of the stress-anxiety-recovery cycle. Selank is relevant to daytime anxiety, cognitive clarity, and stress-related mental fatigue through enkephalinase inhibition, indirect GABAergic modulation, and monoamine activity in limbic regions. DSIP, the delta sleep-inducing peptide, is focused on sleep-phase stress regulation — HPA axis modulation, slow-wave sleep support, nocturnal cortisol patterns, and stress-related sleep maintenance. Selank fits waking anxiety and cognitive function protocols; DSIP fits sleep architecture and recovery-focused protocols. Where comprehensive stress and recovery management is the objective, the two may be considered at different protocol phases. Practitioners evaluating the sleep-phase component can review buy DSIP formulation details for sourcing and specification guidance.

versus Oxytocin

Selank and Oxytocin may both appear in anxiety-related protocol discussions, but they address different anxiety profiles through entirely different neurochemical pathways. Selank is relevant to generalized anxiety, cognitive anxiety, stress-related asthenia, and brain function concerns via enkephalinase inhibition and GABAergic modulation. Oxytocin acts through oxytocin receptor pathways linked to social bonding, trust, attachment, relational anxiety, and sexual health contexts. Selank is the more appropriate tool when generalized anxiety and cognitive enhancement are the primary endpoints; Oxytocin is more relevant when social, relational, or bonding-related mechanisms are central to the protocol. A comprehensive anxiety protocol may include both, each applied to its respective indication. Practitioners assessing the social or relational anxiety component can review buy Oxytocin product details for formulation and sourcing information.

Where Can Practitioners Buy Selank Online?

Selank is available for research purposes only to qualified licensed professionals. When buying online, practitioners should source exclusively from suppliers with verifiable purity documentation, including a certificate of analysis (COA), LOT number traceability, and clear handling and storage specifications. Those looking to check for wholesale buying options should confirm that any supplier meets these documentation standards and that procurement complies with the research-compound regulatory status of Selank in their jurisdiction.

Medical Spa Rx’s professional support team offers sourcing guidance and access to supporting documentation for licensed practitioners evaluating research-grade Selank. For guidance on supplier qualification, purity records, and compliance considerations, contact the professional support team directly.

FAQs

1. What is Selank and what is it used for?

Selank is a synthetic heptapeptide tuftsin analogue developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is registered in Russia as a prescription medicine for generalized anxiety disorder and nootropic use. Outside Russia and Belarus, it is a research compound without approval from the FDA, EMA, or TGA. It is primarily discussed for anxiety modulation, cognitive enhancement, and brain function support.

2. What does Selank do — how does it work?

Selank’s primary mechanism is enkephalinase inhibition, which extends the activity of endogenous enkephalins involved in mood and stress regulation [2]. It also modulates GABAergic neurotransmission, with human neuroimaging data confirming altered amygdala connectivity in healthy participants [4]. Preclinical data additionally support BDNF upregulation in the hippocampus [3], and animal models suggest monoaminergic effects in limbic regions, though human data for the latter remain limited.

3. Is Selank safe — does it cause withdrawal?

Russian clinical studies report Selank as generally well tolerated, with no serious adverse events documented at studied doses and no physical dependence or withdrawal syndrome reported [1]. This is a key distinction from benzodiazepine anxiolytics. Reported side effects are mild — typically nasal irritation with intranasal use or transient headache. Long-term safety data outside Russian trials remain limited.

4. What is the Selank dosage, and how is it given?

The primary route is nasal spray, with practitioner-reported intranasal dosing of 250–750 mcg per nostril, 2–3 times daily, based on Russian clinical parameters. Subcutaneous injectable use is less common, with practitioner-reported dosing of 250–500 mcg once or twice daily. No FDA-validated Selank dosing protocol exists outside authorized Russian clinical settings.

5. How does Selank compare to Semax?

Both are Russian-developed nootropic peptides with domestic regulatory approval. Selank is a calming, anxiolytic nootropic relevant to generalized anxiety, stress-related cognitive symptoms, and mental clarity, with GABAergic modulation confirmed in human neuroimaging [4]. Semax is more cognitively activating and is discussed primarily for attention, processing speed, and neuroprotection via BDNF upregulation and ACTH-like mechanisms. They serve different use cases within the nootropic peptide category.

6. How does Selank compare to DSIP and Oxytocin?

Selank is relevant to daytime generalized anxiety and cognitive function. DSIP addresses sleep-phase HPA regulation, slow-wave sleep support, and stress-related insomnia. Oxytocin is relevant to social bonding, relational anxiety, social stress, and sexual health contexts. These peptides target different pathways and anxiety subtypes and are not simple substitutes for one another.

7. Where can practitioners buy Selank?

Licensed professionals evaluating where to buy Selank wholesale should prioritize verified purity documentation, supplier qualification, and jurisdiction-specific compliance. Medical Spa Rx’s professional support team can provide guidance on sourcing from qualified suppliers and access to supporting documentation, including certificates of analysis. Practitioners should confirm Selank’s research-compound status in their jurisdiction before procurement.

Sources

1. Zozulya AA, Neznamov GG, Siuniakov TS, et al. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
2. Zozulya AA, Kost NV, Yu Sokolov O, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001;131(4):315-317. doi:1023/a:1017979514274
3. Inozemtseva LS, Karpenko EA, Dolotov OV, et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Dokl Biol Sci. 2008;421:241-243. doi:1134/s0012496608040066
4. Panikratova YR, Lebedeva IS, Sokolov OY, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020;490(1):9-11. doi:10.1134/S001249662001007X

The page and all of its displayed contents are for medical professionals, designed to inform only, and not as a replacement for medical advice.